JP2008503591A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503591A5 JP2008503591A5 JP2007518253A JP2007518253A JP2008503591A5 JP 2008503591 A5 JP2008503591 A5 JP 2008503591A5 JP 2007518253 A JP2007518253 A JP 2007518253A JP 2007518253 A JP2007518253 A JP 2007518253A JP 2008503591 A5 JP2008503591 A5 JP 2008503591A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- mono
- aryl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003118 aryl group Chemical group 0.000 claims 66
- 125000001072 heteroaryl group Chemical group 0.000 claims 64
- 125000005843 halogen group Chemical group 0.000 claims 60
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 51
- 229910052799 carbon Inorganic materials 0.000 claims 43
- 125000000623 heterocyclic group Chemical group 0.000 claims 35
- 150000001875 compounds Chemical class 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 27
- 150000001204 N-oxides Chemical class 0.000 claims 25
- 150000003839 salts Chemical class 0.000 claims 25
- 239000012453 solvate Substances 0.000 claims 25
- 229940002612 prodrug Drugs 0.000 claims 24
- 239000000651 prodrug Substances 0.000 claims 24
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 22
- -1 chloro, bromo, fluoro, iodo Chemical group 0.000 claims 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 150000001721 carbon Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 5
- 210000004102 animal cell Anatomy 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 102000044159 Ubiquitin Human genes 0.000 claims 2
- 108090000848 Ubiquitin Proteins 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 241000257303 Hymenoptera Species 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 102000003714 TNF receptor-associated factor 6 Human genes 0.000 claims 1
- 108090000009 TNF receptor-associated factor 6 Proteins 0.000 claims 1
- 230000004721 adaptive immunity Effects 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 230000004097 bone metabolism Effects 0.000 claims 1
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 230000021617 central nervous system development Effects 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 230000005296 lymph node development Effects 0.000 claims 1
- 230000023247 mammary gland development Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000001453 quaternary ammonium group Chemical group 0.000 claims 1
- 230000006128 skin development Effects 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58226104P | 2004-06-22 | 2004-06-22 | |
| US64610205P | 2005-01-21 | 2005-01-21 | |
| PCT/US2005/022157 WO2006002284A1 (en) | 2004-06-22 | 2005-06-22 | Ubiquitin ligase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008503591A JP2008503591A (ja) | 2008-02-07 |
| JP2008503591A5 true JP2008503591A5 (enExample) | 2008-08-14 |
Family
ID=34979690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518253A Pending JP2008503591A (ja) | 2004-06-22 | 2005-06-22 | ユビキチンリガーゼ阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20050282818A1 (enExample) |
| EP (1) | EP1758873A1 (enExample) |
| JP (1) | JP2008503591A (enExample) |
| WO (1) | WO2006002284A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732442B2 (en) | 2003-09-05 | 2010-06-08 | Ono Pharmaceutical Co., Ltd. | Chemokine receptor antagonist and medical use thereof |
| JP5048520B2 (ja) | 2005-02-04 | 2012-10-17 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | Ｅ１活性化酵素の阻害剤 |
| WO2006105127A2 (en) * | 2005-03-31 | 2006-10-05 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| SG169369A1 (en) | 2006-02-02 | 2011-03-30 | Millennium Pharm Inc | Inhibitors of e1 activating enzymes |
| AU2013203433B2 (en) * | 2006-08-08 | 2016-07-28 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| ATE485276T1 (de) | 2006-08-08 | 2010-11-15 | Millennium Pharm Inc | Heteroarylverbindungen als hemmer der e1- aktivierenden enzyme |
| WO2008115259A2 (en) * | 2006-08-10 | 2008-09-25 | Rigel Pharmaceuticals, Inc. | Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| US20100189648A1 (en) * | 2006-11-02 | 2010-07-29 | Lan Huang | Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| ES2304112B1 (es) * | 2007-02-23 | 2009-08-13 | Universidad De Zaragoza | Uso de compuestos como inhibidores de la flavodoxina de helicobacter. |
| ES2304220B1 (es) * | 2007-03-02 | 2009-09-11 | Universidad De Zaragoza | Composicion para el tratamiento de enfermedades infecciosas. |
| ES2304221B1 (es) * | 2007-03-02 | 2009-09-11 | Universidad De Zaragoza | Composicion para el tratamiento de enfermedades infecciosas causadas por helicobacter. |
| WO2008124838A1 (en) * | 2007-04-10 | 2008-10-16 | University Of Maryland, Baltimore | Compounds that inhibit human dna ligases and methods of treating cancer |
| BRPI0811065A2 (pt) * | 2007-06-08 | 2014-12-02 | Abbott Lab | Indazóis 5-heteroaril substituídos como inibidores de quinase |
| US20090054312A1 (en) * | 2007-08-22 | 2009-02-26 | Wolf Dieter A | SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| GB0717982D0 (en) * | 2007-09-14 | 2007-10-24 | Univ Durham | Method and means relating to multiple herbicide resistance in plants |
| EP2231632A2 (en) * | 2008-01-25 | 2010-09-29 | Syngenta Participations AG | 2-cyanophenyl sulfonamide derivatives useful as pesticides |
| WO2010005534A2 (en) * | 2008-06-30 | 2010-01-14 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Proteasome inhibitors for selectively inducing apoptosis in cancer cells |
| HUE025013T2 (hu) | 2009-01-12 | 2016-04-28 | Pfizer Ltd | Szulfonamid-származékok |
| WO2010102286A2 (en) | 2009-03-06 | 2010-09-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Proteasome inhibitors having chymotrypsin-like activity |
| US20120122896A1 (en) * | 2009-05-08 | 2012-05-17 | Pike Pharma Gmbh | 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication |
| UA108986C2 (uk) | 2009-05-14 | 2015-07-10 | Мілленніум Фармасьютікалз, Інк. | Кристалічна форма гідрохлориду ((1s,2s,4r)-4-{4-[(1s)-2,3-дигідро-1h-інден-1-іламіно]-7h-піроло[2,3-d]піримідин-7іл}-2-гідроксициклопентил)метилсульфамату (варіанти) |
| GB201007187D0 (en) | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination modulators |
| JP5872552B2 (ja) | 2010-07-09 | 2016-03-01 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 化学化合物 |
| ES2659763T3 (es) | 2011-02-14 | 2018-03-19 | The Regents Of The University Of Michigan | Composiciones y procedimientos para el tratamiento de obesidad y trastornos relacionados |
| SG11201400102WA (en) | 2011-08-24 | 2014-03-28 | Millennium Pharm Inc | Inhibitors of nedd8-activating enzyme |
| WO2013052943A2 (en) * | 2011-10-06 | 2013-04-11 | The Regents Of The University Of Michgian | Small molecule inhibitors of mcl-1 and uses thereof |
| ES2396764B1 (es) * | 2011-11-02 | 2013-12-19 | Universidad Autónoma de Madrid | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. |
| US9290500B2 (en) | 2012-02-17 | 2016-03-22 | Millennium Pharmaceuticals, Inc. | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
| GB201212456D0 (en) | 2012-07-12 | 2012-08-29 | Univ Sheffield | Treatment of muscular dystrophy |
| JP6219955B2 (ja) | 2012-08-24 | 2017-10-25 | トレヴェンティス コーポレイションＴｒｅｖｅｎｔｉｓ Ｃｏｒｐｏｒａｔｉｏｎ | ベンゾフラザン抗アミロイド化合物および方法 |
| US9365581B2 (en) | 2013-05-02 | 2016-06-14 | The Regents Of The University Of Michigan | Deuterated amlexanox |
| US9464311B2 (en) * | 2013-05-02 | 2016-10-11 | E3X Bio, Inc. | Method for identifying modulators of ubiquitin ligases |
| WO2015002994A2 (en) | 2013-07-02 | 2015-01-08 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of sumo activating enzyme |
| RS58976B1 (sr) * | 2014-02-27 | 2019-08-30 | Treventis Corp | Antiamiloidna jedinjenja koja sadrže benzofuran |
| US20170029388A1 (en) * | 2014-04-11 | 2017-02-02 | Intercontinental Great Brands Llc | Treatment of Neurodegenerative Diseases with Asparagine Endopeptidase (AEP) Inhibitors and Compositions Related Thereto |
| HUE045748T2 (hu) | 2014-07-01 | 2020-01-28 | Millennium Pharm Inc | Heteroaril vegyületek mint SUMO aktiváló enzimek inhibitorai |
| EP3221299A1 (en) | 2014-11-21 | 2017-09-27 | BSIM2 Biomolecular Simulations Lda. | 2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof |
| EP3307723B1 (en) | 2015-06-15 | 2020-11-11 | BSIM2 - Biomolecular Simulations, S.A. | Bis-furan derivatives as transthyretin (ttr) stabilizers and amyloid inhibitors for the treatment of familial amyloid polyneuropathy (fap) |
| EP3407974A4 (en) | 2016-01-29 | 2019-08-28 | The Regents Of The University Of Michigan | Amlexanox Analogs |
| PH12019500056B1 (en) | 2016-07-12 | 2024-01-31 | Revolution Medicines Inc | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
| CN106565694B (zh) * | 2016-10-09 | 2019-10-15 | 北京化工大学 | 一种nbd-有机胺类荧光探针及其制备方法和应用 |
| SG11201906412SA (en) | 2017-01-23 | 2019-08-27 | Revolution Medicines Inc | Pyridine compounds as allosteric shp2 inhibitors |
| BR112019015075A2 (pt) * | 2017-01-23 | 2020-03-10 | Revolution Medicines, Inc. | Compostos bicíclicos como inibidores de shp2 alostéricos |
| US10888564B2 (en) | 2017-01-26 | 2021-01-12 | Institute For Cancer Research | Inhibitors of HIV-1 integrase multimerization |
| SG11202002941WA (en) | 2017-10-12 | 2020-04-29 | Revolution Medicines Inc | Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors |
| CA3084058A1 (en) | 2017-12-15 | 2019-06-20 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric shp2 inhibitors |
| US20230103965A1 (en) * | 2020-02-02 | 2023-04-06 | Ramot At Tel-Aviv University Ltd. | Novel activators of the lipidating transporter atp binding cassette protein type 1 (ab-ca1) and therapeutic uses thereof |
| CN113149930B (zh) * | 2021-04-16 | 2022-09-02 | 天津大学 | 一种细胞糖转运通道抑制剂 |
| CN113582940B (zh) * | 2021-09-07 | 2022-05-20 | 四川大学华西医院 | 一类脂滴特异性荧光探针及其合成方法 |
| WO2025117672A1 (en) * | 2023-12-01 | 2025-06-05 | Hotspot Therapeutics, Inc. | Indazolyl-piperidine sulfonamides and related compounds and their use in therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604926D0 (en) * | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
| GB9622386D0 (en) * | 1996-10-28 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| DE10000739A1 (de) * | 2000-01-11 | 2001-07-12 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| DE10045599B4 (de) * | 2000-09-15 | 2004-06-03 | Wella Ag | Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren |
| US20020173524A1 (en) * | 2000-10-11 | 2002-11-21 | Tularik Inc. | Modulation of CCR4 function |
| JP2005511625A (ja) * | 2001-11-14 | 2005-04-28 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 向精神薬としてのピラゾール誘導体 |
| GB0215650D0 (en) * | 2002-07-05 | 2002-08-14 | Cyclacel Ltd | Bisarylsufonamide compounds |
| US7491718B2 (en) * | 2002-10-08 | 2009-02-17 | Abbott Laboratories | Sulfonamides having antiangiogenic and anticancer activity |
| US20040157836A1 (en) * | 2002-10-08 | 2004-08-12 | Comess Kenneth M. | Sulfonamides having antiangiogenic and anticancer activity |
| WO2005007621A2 (en) * | 2003-05-30 | 2005-01-27 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| WO2005037845A1 (en) * | 2003-10-17 | 2005-04-28 | Rigel Pharmaceuticals, Inc. | Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
-
2005
- 2005-06-22 WO PCT/US2005/022157 patent/WO2006002284A1/en not_active Ceased
- 2005-06-22 EP EP05767481A patent/EP1758873A1/en not_active Withdrawn
- 2005-06-22 US US11/158,957 patent/US20050282818A1/en not_active Abandoned
- 2005-06-22 JP JP2007518253A patent/JP2008503591A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7126541B2 (ja) | ハンチントンタンパク質のイメージング用プローブ | |
| JP2016514719A5 (enExample) | ||
| JP2023010738A (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| JP2015502387A5 (enExample) | ||
| JP5864589B2 (ja) | 細菌トポイソメラーゼｉｉ阻害性２−エチルカルバモイルアミノ−１，３−ベンゾチアゾール−５−イル類 | |
| JP2018115201A5 (enExample) | ||
| JP2018529739A5 (enExample) | ||
| JP6424234B2 (ja) | ８−（ピペラジン−１−イル）−１，２，３，４−テトラヒドロ−イソキノリン誘導体 | |
| JP2016514718A5 (enExample) | ||
| JP2015537017A5 (enExample) | ||
| JP2018519357A5 (enExample) | ||
| JP2016525075A5 (enExample) | ||
| JP2018529650A5 (enExample) | ||
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| JP2016525130A5 (enExample) | ||
| JP2016506368A5 (enExample) | ||
| JP2017528519A5 (enExample) | ||
| JP2017538721A5 (enExample) | ||
| JP2015529224A5 (enExample) | ||
| HRP20230472T1 (hr) | Novi derivati hidroksikiseline, postupak njihove priprave i farmaceutski sastavi koji ih sadrže | |
| JP2013523803A5 (enExample) | ||
| JP2017513879A5 (enExample) | ||
| JP2016531858A5 (enExample) | ||
| JP2020536116A5 (enExample) | ||
| JP2013540755A5 (enExample) |